27 Hellenic Conference of Clinical Oncology
Table of Contents page: Journal of Thoracic Oncology
Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression and Survival in Operable Squamous-Cell Laryngeal Cancer | PLOS ONE
PDF) Lung Cancer in Greece
ΔΗΜΟΣΙΕΥΣΕΙΣ | Ιωάννης Μούντζιος
Giannis MOUNTZIOS | Consultant Medical Oncologist | Consultant Medical Oncologist | National and Kapodistrian University of Athens, Athens | uoa | Medical Oncology | Research profile
Giannis MOUNTZIOS | Consultant Medical Oncologist | Consultant Medical Oncologist | National and Kapodistrian University of Athens, Athens | uoa | Medical Oncology | Research profile
PDF) Unusual Sites of Metastatic Malignancy: CASE 1. Cardiac Metastasis in Hepatocellular Carcinoma | francesco cortese and Francesco Torino - Academia.edu
PDF) A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First or Second Generation EGFR
Inmate cancer patient - Highlighting the importance of a holistic approach to oncological care
PDF) Cardioprotective Strategies from Cardiotoxicity in Cancer Patients: A Comprehensive Review
Adrenal Incidentalomas in Cancer Patients Are Not Always “Innocent”: A Case Report and Review of the Literature
Η ογκολογία ακριβείας μεταμορφώνει τις αντικαρκινικές θεραπείες - Oncolife - Δρ. Ιωάννης Μούντζιος, Ογκολόγος - Παθολόγος
Hypertension management in cardio-oncology | Journal of Human Hypertension
PDF) Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study
Hypertension management in cardio-oncology | Journal of Human Hypertension
Molecular Epidemiology and Treatment Patterns of Patients With EGFR Exon 20-Mutant NSCLC in the Precision Oncology Era: The European EXOTIC Registry - JTO Clinical and Research Reports
PDF) A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First- or Second-Generation EGFR Tyrosine
Ramon Andrade de Mello Álvaro Tavares Giannis Mountzios Editors (iMOP) - Principles of Medical Oncology
George Pavlakis CV | PDF
JCDD | Free Full-Text | Cardioprotective Strategies from Cardiotoxicity in Cancer Patients: A Comprehensive Review
Giannis MOUNTZIOS | Consultant Medical Oncologist | Consultant Medical Oncologist | National and Kapodistrian University of Athens, Athens | uoa | Medical Oncology | Research profile
Table of Contents page: Journal of Thoracic Oncology
PDF) Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia
Directory | PDF | Nursing | Cancer
PDF) An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with
Lung Cancer in Greece - Journal of Thoracic Oncology
Ανοσοθεραπεία του καρκίνου, η υπόσχεση του μέλλοντος. - Oncolife - Δρ. Ιωάννης Μούντζιος, Ογκολόγος - Παθολόγος
